EXAS vs PROF · rev $2.76B vs rev $10.7M
EXACT Sciences Corporation (EXAS) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
EXAS currently screens at market cap $20.03B. PROF currently screens at market cap $238.7M.
Not investment advice. Open the EXAS and PROF stock pages for the full models.
Not investment advice.